1 / 34

Palliative Management Of:

Palliative Management Of:. Nausea And Vomiting Dyspnea Secretions Delirium. Mike Harlos MD, CCFP, FCFP Medical Director, WRHA Palliative Care Professor, University of Manitoba Faculty of Medicine. MECHANISM OF NAUSEA AND VOMITING. vomiting centre in reticular formation of medulla

ama
Télécharger la présentation

Palliative Management Of:

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Palliative Management Of: • Nausea And Vomiting • Dyspnea • Secretions • Delirium Mike Harlos MD, CCFP, FCFP Medical Director, WRHA Palliative Care Professor, University of Manitoba Faculty of Medicine

  2. MECHANISM OF NAUSEA AND VOMITING • vomiting centre in reticular formation of medulla • activated by stimuli from: • Chemoreceptor Trigger Zone (CTZ) • area postrema, floor of the fourth ventricle • outside blood-brain barrier (fenestrated venules) • Upper GI tract & pharynx • Vestibular apparatus • Higher cortical centres

  3. Cortex CTZ GI VOMITING CENTRE Vestibular

  4. Stimuli Of Vomiting Pathways

  5. PRINCIPLES OF TREATING NAUSEA & VOMITING • Treat the cause, if possible and appropriate • Environmental measures • Antiemetic use: • anticipate need if possible • use adequate, regular doses • aim at presumed receptor involved • combinations if necessary • anticipate need for alternate routes

  6. D D D 5HT 5HT 5HT 5HT 2 2 2 M M M VOMITING CENTRE H1 H1 CB1 H1 Effector Organs H1 CB1 Muscarinic Cannabinoid Dopamine Serotonin Histamine

  7. From: Nausea and vomiting associated with cancer chemotherapy: drug management in theory and in practice Arch. Dis. Child.2004;89;877-880 E S Antonarakis and R D W Hain

  8. DyspneaInPalliative Care

  9. DYSPNEA: An uncomfortable awareness of breathing

  10. DYSPNEA: “...the most common severe symptom in the last days of life” Davis C.L. The therapeutics of dyspnoea Cancer Surveys 1994 Vol.21 p 85 - 98

  11. Approach To The Dyspneic Palliative Patient • Two basic intervention types: • Non-specific, symptom-oriented • Disease-specific

  12. Simple Non-Specific Measures In Managing Dyspnea • calm reassurance • patient sitting up / semi-reclined • open window • fan

  13. Non-Specific Pharmacologic Interventions In Dyspnea • Oxygen - hypoxic and ? non-hypoxic • Opioids - complex variety of central effects • Chlorpromazine or Methotrimeprazine - some evidence in adult literature; caution in children due to potential for dystonic reactions • Benzodiazepines - literature inconsistent but clinical experience extensive and supportive

  14. TREAT THE CAUSE OF DYSPNEA - IF POSSIBLE AND APPROPRIATE • Anti-tumor: chemo/radTx, hormone, laser • Infection • Anemia • CHF • SVCO • Pleural effusion • Pulmonary embolism • Airway obstruction

  15. DISEASE-SPECIFIC MEDICATIONS FOR DYSPNEA • Corticosteroids • obstruction: SVCO, airway • lymphangitic carcinomatosis • radiation pneumonitis • Furosemide • CHF • lymphangitic carcinomatosis • Antibiotics • Anticoagulation– pulm. embolus • Bronchodilators • Transfusion

  16. Opioids in Dyspnea • Uncertain mechanism • Comfort achieved before resp compromise; rate often unchanged • Often patient already on opioids for analgesia; if dyspnea develops it will usually be the symptom that leads the need for titration • Dosage should be titrated empirically; may easily reach doses commonly seen in adults • May need rapid dose escalation in order to keep up with rapidly progressing distress

  17. A COMMON CONCERN ABOUT AGGRESSIVE USE OF OPIOIDS IN THE FINAL HOURS How do you know that the aggressive use of opioids for pain or dyspnea doesn't actually bring about or speed up the patient's death?

  18. SUBCUTANEOUS MORPHINE IN TERMINAL CANCER Bruera et al. J Pain Symptom Manage. 1990; 5:341-344

  19. Typically, with excessive opioid dosing one would see: • pinpoint pupils • gradual slowing of the respiratory rate • breathing is deep (though may be shallow) and regular

  20. COMMON BREATHING PATTERNS IN THE FINAL HOURS Cheyne-Stokes Rapid, shallow “Agonal” / Ataxic

  21. Palliative Management of Secretions

  22. Secretions - Prevalence At Study Entry And In Last Month Of LifeUK Children’s Cancer Study Group/Paediatric Oncology Nurses Forum SurveyGoldman A et al; Pediatrics 2006; 117; 1179-1186

  23. Suctioning Increased Secretions Mucosal Trauma Managing Secretions in Palliative Patients • Factors influencing approach management: • Oral secretions vs.. lower respiratory • Level of alertness and expectations thereof • Proximity of expected death • “Death Rattle” – up to 50% in final hours of life • At times the issue is more one of creating an environment less upsetting to visiting family/friends • Suctioning: “If you can see it, you can suction it”

  24. CONGESTION IN THE FINAL HOURS “Death Rattle” • Positioning • ANTISECRETORY: Scopolamine, glycopyrrolate • Consider suctioning if secretions are: • distressing, proximal, accessible • not responding to antisecretory agents

  25. Atropine Eye DropsFor Palliative Management Of Secretions • Atropine 1% ophthalmic preparation • Local oral effect for excessive salivation/drooling • Dose is usually 1 – 2 drops SL or buccal q6h prn • There may be systemic absorption… watch for tachycardia, flushing

  26. Delirium in Palliative Care

  27. Definition Etiologically non-specific global cerebral dysfunction associated with changes in LOC, attention, thinking, perception, memory, psychomotor behavior, emotion and the sleep/wake cycle

  28. DSM-IV Criteria • Change in consciousness with reduced ability to focus, sustain or shift attention • Change in cognition (e.g., memory, disorientation, change in language, perceptual disturbance) that is not dementia • Abrupt onset (hours to days) with fluctuation • Evidence of medical condition judged to be etiologically related to disturbance

  29. Characteristics • Abrupt onset • Disorientation, fluctuation of symptoms • Hypoactive vs.. hyperactive (restlessness, agitation, aggression) vs. mixed • Changes in sleeping patterns • Incoherent, rambling speech • Fluctuating emotions • Activity that is disorganized and without purpose

  30. Delirium Types • Hypoactive • confusion, somnolence,  alertness • Hyperactive • agitation, hallucinations, aggression • Mixed (>60%) • features of both

  31. Prevalence of Delirium • 20% - 44% on admission to a palliative care unit (common reason for admission) • 28% - 45% of patients developed delirium while on the palliative care unit • 68% - 90% prior to death • Lawlor et al (J Pall Care 1998) • n = 103 pts • 50% of episodes reversible • Terminal delirium in 88% • Hyperactive (5%) vs. hypoactive (47%) • Mixed (48%) most common

  32. Delirium versus Dementia DeliriumDementia Abrupt onset Insidious onset Decreased/Fluctuating LOC LOC intact, alert Erratic behaviour Consistent behaviour Sleep/wake cycle change Minimal changes Reversible (theoretically) Irreversible

  33. Causes Of Delirium In Palliative Care • Tumour • Primary, metastatic, leptomeningeal, paraneoplastic syndrome • Metabolic / physiologic • hypercalcemia • Hyponatremia (hypernatremia less commonly) • ↑ or ↓ glucose • anemia, hypoxia • CO2 • Renal or liver failure • Infection – UTI, pneumonia, biliary tract, wounds • Medication administration – opioids, antiemetics (esp. anticholinergic), sedatives, antisecretory • Medication / Drug withdrawal • Etc…..

  34. Management Of Delirium In Palliative Care • Environmental • Quite, private setting: single room if possible • Low lighting, calendar, clock, familiar objects • Minimal room changes with unnecessary distractions • Fix the Fixable – if possible and appropriate • Help family navigate complex choices and non-choices, dictated by how the patient would guide care if that were possible • Effective sedation – with frank discussion of anticipated course • If delirium irreversible, goal of care is sedation • Sedation does not hasten the dying process • Will facilitate meaningful visiting • Encourage communication, even though patient not interactive

More Related